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Mouse myeloma protein 315  (IgA, k2), when mixed with complete Freund's 
adjuvant, elicits antibodies specific for idiotypic determinants that require as- 
sembled (light [L] plus  heavy chain  [H])  chains for their expression (1).  Pre- 
vious studies from this laboratory have revealed that the antibody response of 
BALB/c mice to M315 is T  helper cell (Th)-dependent, and that free variable 
region  light chain  315  (VL-315)elicits  Th  that  respond  to  a  boost  with  the 
complete M315  (2).  In contrast, VH-315 does not induce Th of BALB/c mice 
(H-2  d) that respond to M315 (2).  In fact, the responses of Th to the VL and VH 
domains are governed by H-2-1inked immune response genes: the H-2  d haplotype 
conferred high responsiveness to VL-315 and low responsiveness to V.-315, while 
the H-2  k haplotype conferred high responsiveness to VH-315 and low responsive- 
ness to VL-315 (3, 4). The aim of the present study was to elucidate the structural 
basis  for the  expression  of epitopes  of VL-315  recognized by Th  of BALB/c 
(H-2  d) mice. 
Materials and Methods 
Mice.  BALB/c/A/Bom mice purchased from GI. Bomholtg~rd, Ry, Denmark or bred 
at our institute were used throughout. 
Antigens.  Isolation of M315, and preparation of its Fab, Fv, VM, and VL fragments, 
315  and preparation of  4-hydroxy-3-iodo-5-nitrophenylacetyi preparation of(NIP)-Fab  have 
been described (2). 
Cyanogen Bromide (CNBr) Cleavage Of VL-315 and Isolation of  Fragments.  CNBr fragments 
were produced as described  (5). Briefly, 40 mg solid CNBr was added to 20 mg fully 
reduced and alkylated VL-315 (4) dissolved in 70% HCOOH. After incubation for 24 h 
at room temperature, the fragments were lyophilized and dissolved in 2 ml 9% HCOOH 
and subjected to gel filtration on Sephadex G-50 superfine (see Fig. 1). Polypeptides in 
Coomassie brilliant blue-stained sodium dodecyl sulfate-polyacrylamide gel electrophoresis 
(SDS-PAGE) gels (6)  were  detected with an  LKB Ultroscan  laser densitometer (LKB 
Instruments, Inc., Gaithersburg,  MD). Fractions that only contained one of  the two major 
bands resulting from the cleavage were dissolved in 0.2 M Tris/HCl, pH 8.3, pooled, and 
stored at -20 °  C. Molecular weight standards were glucagon (moi wt 3,647) and uncleaved 
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VL (mol wt ,~ 14,000). The protein concentration of the isolated fragments was measured 
by the method of Bradford (7), using uncleaved VL as the standard. 
Enzyme-linkedlmmunosorbentAssay(ELISA)ofAnti-NIPAntibodies.  96-well Linbro micro- 
titration plates were incubated with 200 #1 NIPs-bovine serum albumin (BSA) (5 #g/mi) 
overnight at room temperature. Wells were emptied and 220 #1 5% normal rabbit serum 
was added for 2 h. After three washes with phosphate-buffered saline (PBS) containing 
0.02%  Tween 20, duplicates of serum diluted 1:100 in PBSA (200 #1) were added and 
incubated for 2 h. After washing, the wells received 200/zl alkaline phosphatase-  (Sigma 
Chemical  Co.,  St.  Louis,  MO) conjugated affinity-purified  rabbit anti-mouse  ~  chains 
antibodies.  Finally, after another  2-h  incubation and  three washes, the  wells received 
enzyme  substrate  (para-nitrophenyl-phosphate;  Sigma  Chemical  Co.)  diluted  in  1  M 
diethanolamine,  pH 9.8, 0.5 x  1O  -s M MgCi~ (200 #!:1 mg/ml).  Absorbances at 405 nm 
were read after 45-60 min  in a Titertek Multiscan  (Flow Laboratories, Inc.,  McLean, 
VA) spectrophotometer. The absorbances were corrected for background by using normal 
sera.  A standard curve was obtained using  affinity-purified  mouse anti-NIP antibodies 
(range,  0.8-100  #g/mi).  This  technic  was also  used for  measuring  antibodies  to  the 
fragments of VL-315 (see Fig. 3). 
Anti,era.  Six BALB/c mice were immunized  two times with either the N- or the C- 
terminal  CNBr fragments of VL-315. The first immunization  (0.2 ml total) was distributed 
in the rear footpads and intraperitoneally and consisted of an emulsion of an equal volume 
of 70 #g peptide dissolved in 0.2 M Tris/HCI, pH 8:2, and complete Freund's adjuvant 
containing  1 mg/ml Mycobacterium tuberculosis (Behringwerke).  The second injection  (100 
#g peptide in 0.2 M Tris/HCi, pH 8.3) was given intraperitoneally 30 d later.  The mice 
were bled 14 d after the last injection and the antisera against each fragment were pooled. 
Immunization and Cell Transfer.  Carrier-specific  Th cells were primed by one injection 
in each rear footpad of an emulsion consisting of an equal volume of 50 #g of either V~ 
or the N- or C-terminal  CNBr fragment, in complete Freund's adjuvant.  12-30 d later 
(see Table I), the popliteal  lymph node cells were harvested and pooled with spleen cells 
from animals primed 8 wk before with 200 #g NIP-keyhole limpet  hemocyanin (KLH) 
emulsified  in complete Freund's adjuvant. The cells were washed once and transferred 
intravenously  to x-irradiated (500 rad) BALB/c recipients.  Each recipient was given one 
popliteal lymph node equivalent of carrier-primed cells plus one-half spleen equivalent of 
NIP-primed cells. The recipients  were boosted the following day with one injection  (0.2 
ml i.p.) of 200 #g NIPs-Fab  31s in saline. 
Results 
CNBr Fragments of VL-315.  Cleavage of the VL-315 fragment at its methionme 
residue at position 87 (5) yielded two major fragments that were separated on a 
Sephadex G-50  superfine (Pharmacia  Fine Chemicals,  Piscataway,  NJ) column 
(Fig.  1). Fractions which by SDS-PAGE were pure with respect to the two major 
fragments were pooled. The protein in each pool migrated as a single band by 
SDS-PAGE with molecular weights of about  10,000 and  4,000 (Fig.  2),  which 
are the expected sizes of V~-315 fragments resulting from cleavage at Met  87. 
The N-terminal amino acid sequence of the smallest (4,000 mol wt) fragment 
was Tyr-Phe-Cys (carboxymethylated)-Ala, which is identical with positions 88- 
91 of VL-315 (5). This proved that the 4,000 mol wt fragment corresponded to 
the C-terminal part of VL-315. However, ,~ 10% of the peptides in this pool had 
N-terminal  amino acid sequence Phe-Arg-Asn and thus represented  fragments 
resulting from slight CNBr cleavage at tryptophane (8) in position 93 (5). 
The N-terminal amino acid of the large (10,000 mol wt) fragment is blocked 
(5). On the basis of these facts and the molecular weight data, we conclude that 
this fragment represented the N-terminal  1-86 amino acids of VL-315. JORGENSEN,  BOGEN, AND  HANNESTAD  BRIEF  DEFINITIVE  REPORT  2185 
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FIGURE  1.  Gel filtration of the CNBr fragments of VL-315 applied on Sephadex G-50 
superfine in 9% CHOOH (180 X 2.5 cm column). Flow  rate; 26 ml/h. 5.3-ml fractions  were 
collected per tube. Horizontal bars indicate the collected fractions that contained the N- 
terminal (10 K) and C-terminal  (4 K) fragments. 
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FIGURE 2.  SDS-PAGE (17%). (A) Unc[eaved VL, ~14,000 mol wt (14 K). (B) N-terminal 
fragment of VL, containing residues 1-86 (10 K). (C) C-terminal fragment of VL, containing 
residues 88-114/117 (4 K!. (D) glucagon, 3,647 mol wt. 
Antibody Response of BALB]c Mice to the CNBr Fragments Of VL-315.  Sera from 
mice immunized with the CNBr fragments were tested by ELISA. As seen in 
Fig.  3A,  antibodies  against  the  small  C-terminal  fragment  reacted  with  the 
homologous antigen and VL-315, but not with the large N-terminal fragment or 
V.-315. Furthermore, antibodies against the large N-terminal fragment reacted 
with the homologous antigen and VL-315 but not with the C-terminal fragment 
or  V,-315.  This  demonstrated  that  both  fragments  were  immunogenic  for 
BALB/c animals and further attested to the purity of the CNBr fragments. 
Fragment 88-1141117  Elicits Th  That  Respond to  NIP3-FAB  3x5.  In  all  four 
experiments,  recipients  that  received  lymph node or  spleen  cells  from  mice 
primed with intact VL-315 or its C-terminal fragment responded significantly (P 
<  0.005)  to  a  boost  with  NIP3-Fab  3x5  by  an  augmented anti-NIP  antibody 
response  (Table  I)  compared  with  mice  that  received  cells  from  minimum 2186  J~RGENSEN,  BOGEN,  AND  HANNESTAD  BRIEF  DEFINITIVE  REPORT 
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FIGURE  3.  Specificity of BALB/c antisera against two fragments of VL-315 in ELISA. (A) 
Anti-C-terminal (4 K), (B) anti-N-terminal (10 K). The antisera were diluted  1:20. Microtiter 
plates were coated with VL-315, 10 K, 4 K, or Vr315  (5 ¢~g]ml). 
TABLE  I 
VL and its C-Terminal but not its N-Terminal Fragment Elicit M315-specific  Helper Cells that 
Respond to a Boost with NIPs-Fab 3~5 
Group  Helper cell priming 
Secondary, day 10 anti-NIP responses (#g/ml) in recipients* 
Exp. 1  Exp. 2  Exp. 3  Exp. 4 
I  MEM  <0.8  <0.8  1.3 (0.4)  <0.8 
2  VL  24.90 (2.5)*  5.6  ! (1.7)  38.30 (12.3)  9.1! (0.8) 
3  N-terminal fragment  2.1 (0.9)  <0.8  2.5 (0.5)  Not done 
4  C-terminal fragment  44.1! (2.5)  15.6! (4.7)  36.6  ! (12.9)  3.9! (1.3) 
In  each experiment, the number of animals per group was five to seven. The time between priming and 
intravenous transfer of popliteal lymph node helper cells was 12 d in experiments 1 and 3, and 30 d in experiment 
2. In experiment 4, recipients received one-half spleen equivalent of NIP-BSA and one-half spleen equivalent of 
carrier-primed cells harvested 6 wk after priming. 
* Standard error of the mean in parentheses. 
* Complete Freund's adjuvant mixed with minimal essential medium. 
! P < 0.005 when compared with group 1 or 3 (Wilcoxon two sample test). 
essential  medium  (MEM)-primed  animals.  In  marked  contrast,  the  large  N- 
terminal fragment did not elicit cells able to help the responses of NIP-primed 
B cells to a boost with NIPrFab sl~ (Table I). 
Discussion 
The CNBr  fragment of VL-315  that contained the epitope in question was 
detected by an  experimental system described by Mitchison (9;  and  Materials 
and Methods). It was found that lymphocytes from animals primed with isolated 
VL-315 or its C-terminal fragment 88-114/117, the latter consisting of the third 
hypervariable region, the J-region,  and 5-7  amino acids of the C  region (10), 
permitted the development of significant anti-NIP antibody responses in recipi- 
ents boosted with NIP-Fab s15, indicating that these cells contained helper cells 
that recognized the assembled VL of Fab 31~. By contrast, the large  N-terminal 
fragment  1-86, which contained the first and second hypervariable region and 
framework regions, did not elicit Th that recognized Fab  s~5. Using this assay for 
Th activity, we have in several  previous experiments (2,  11)  shown that anti- 
Thy-1.2 plus C' treatment of the iymphocytes primed with VL  3~5 or L  3~5 abolished 
or  greatly  diminished  the  adoptive  anti-NIP  responses.  The  assay  therefore 
undoubtedly detects the effects of Th on anti-NIP antibody-producing B cells. JORGENSEN,  BOGEN,  AND  HANNESTAD  BRIEF  DEFINITIVE REPORT  2187 
The results should be considered in light of the fact that the V region of k23a5 
expresses four somatic mutations of the germline ~,2 gene:  Va138 ~  Ile  3s and 
Tyr94Ser95Thr  96 ~  Phe94Argg~Asn  96 (12).  An attractive possibility is therefore 
that one or more amino acids of the mutated triplet in the third hypervariable 
region are essential for the expression of the antigenic site recognized by Th in 
our experiments. 
Interestingly, Sakato et al. (13) recently demonstrated that a single intravenous 
injection of M315 in complete Freund's adjuvant elicited T  suppressor cells that 
suppressed  the  delayed-type hypersensitivity responses of the  M315  idiotype. 
However, suppression was not induced by two other ~2 chains (L  952 and La-13). 
Since the amino acid sequence of L s-13 is identical with the germline ~2 V gene 
(1 1), these results (13) implied that the distinctive mutated triplet of the third 
hypervariable region of Vr-315 was most likely responsible for expression of the 
epitope recognized by T  suppressor cells.  However,  the precise submolecular 
localization  of this  antigenic  site  is  uncertain  because  it  is  possible  that  the 
mutated amino acids could give rise to distant conformational effects. Since the 
Th of the present study do recognize unfolded V~-315 (4), in contrast to the T 
suppressor cells studied by Sakato and his colleagues, it should be possible to 
determine the precise structural basis of the VL-315 region epitope recognized 
by BALB/c Th. 
It is notable that both the N-terminal and C-terminal CNBr fragments of VL- 
315  elicited antibody responses in BALB/c mice.  Since it is highly likely that 
these antibody responses were Th dependent, it follows that also fragment 1-86 
is recognized by Th.  Why were these putative Th not detected in our helper 
assay? One possible explanation is that the epitope of the N-terminal, in contrast 
to the C-terminal fragment, is structurally hidden or functionally quenched when 
the  VL domain  interacts  with  the  V,  domain  in  Fab  3~s, which  was  used  for 
challenge of the 1-86 peptide-primed Th. This phenomenon has been described 
by Bogen et al. (14) for the ~1 L chain of myeloma protein J558. In this instance, 
LJ558-primed Th responded to a  challenge with the isolated L  J~s but not to the 
complete myeloma protein J558. 
As  discussed previously (4),  it  is possible  that  the Th  of the  present  study 
function in the idiotype network (15). If we consider M315 as "antibody 1" and 
the Th as an analogue of antiidiotypic "antibody 2," the Th could elicit nonspe- 
cific parallel sets of clones, i.e., clones bearing antigenic sites that resemble that 
of the C-terminal fragment of VL-315 but with VH unrelated to V.-315. 
Summary 
Isolated variable region light chain 315 (V,-315), the VL domain of a myeloma 
protein of BALB/c origin, induces T  cells of BALB/c (H-2 a) mice that help the 
adoptive  secondary  anti-4-hydroxy-3-iodo-5-nitrophenylacetyl  (NIP)  antibody 
response to NIP-Fab 315. The location of the epitope recognized by helper cells 
was examined with two fragments of VL-315, obtained by cleavage with cyanogen 
bromide at Met  sT. Both N-terminal fragment 1-86 and C-terminal fragment 88- 
1 14/1 17 elicited BALB/c antibodies that bound to the respective fragments and 
to VL-315. By contrast, only fragment 88-1 14/1 17, which consists of the third 
hypervariable region, J  region, and 5-7  amino acids of the C  region, induced 
helper cells that augmented the anti-NIP response to NIP-Fab 315. 2188  J~RGENSEN,  BOGEN, AND  HANNESTAD  BRIEF  DEFINITIVE  REPORT 
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